{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ammi majus", "HepG2", "apoptosis", "coumarins", "molecular docking", "topoisomerase II", "xanthotoxin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35164207", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "29"}], "Language": ["eng"], "ELocationID": ["943", "10.3390/molecules27030943"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "29"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Potential Anticancer Activity of the Furanocoumarin Derivative Xanthotoxin Isolated from <i>Ammi majus</i> L. Fruits: In Vitro and In Silico Studies.", "Abstract": {"AbstractText": ["<i>Ammi majus</i> L., an indigenous plant in Egypt, is widely used in traditional medicine due to its various pharmacological properties. We aimed to evaluate the anticancer properties of <i>Ammi majus</i> fruit methanol extract (AME) against liver cancer and to elucidate the active compound(s) and their mechanisms of action. Three fractions from AME (Hexane, CH<sub>2</sub>Cl<sub>2</sub>, and EtOAc) were tested for their anticancer activities against HepG2 cell line in vitro (cytotoxicity assay, cell cycle analysis, annexin V-FITC apoptosis assay, and autophagy efflux assay) and in silico (molecular docking). Among the AME fractions, CH<sub>2</sub>Cl<sub>2</sub> fraction revealed the most potent cytotoxic activity. The structures of compounds isolated from the CH<sub>2</sub>Cl<sub>2</sub> fraction were elucidated using <sup>1</sup>H- and <sup>13</sup>C-NMR and found that Compound <b>1</b> (xanthotoxin) has the strongest cytotoxic activity against HepG2 cells (IC<sub>50</sub> 6.9 \u00b1 1.07 \u00b5g/mL). Treating HepG2 cells with 6.9 \u00b5g/mL of xanthotoxin induced significant changes in the DNA-cell cycle (increases in apoptotic pre-G1 and G2/M phases and a decrease in the S-phase). Xanthotoxin induced significant increase in Annexin-V-positive HepG2 cells both at the early and late stages of apoptosis, as well as a significant decrease in autophagic flux in cancer compared with control cells. In silico analysis of xanthotoxin against the DNA-relaxing enzyme topoisomease II (PDB code: 3QX3) revealed strong interaction with the key amino acid Asp479 in a similar fashion to that of the co-crystallized inhibitor (etoposide), implying that xanthotoxin has a potential of a broad-spectrum anticancer activity. Our results indicate that xanthotoxin exhibits anticancer effects with good biocompatibility toward normal human cells. Further studies are needed to optimize its antitumor efficacy, toxicity, solubility, and pharmacokinetics."]}, "AuthorList": [{"Identifier": ["0000-0002-2181-7090"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt."}], "LastName": "Issa", "ForeName": "Marwa Y", "Initials": "MY"}, {"Identifier": ["0000-0001-8973-6847"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Biology Department, Genetic Engineering and Biotechnology Institute, University of Sadat City, Sadat City 32897, Egypt."}], "LastName": "Elshal", "ForeName": "Mohamed F", "Initials": "MF"}, {"Identifier": ["0000-0002-7278-732X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Department, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt."}], "LastName": "Fathallah", "ForeName": "Noha", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt."}], "LastName": "Abdelkawy", "ForeName": "Mostafa A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Arab Company for Pharmaceuticals and Medicinal Plants, El-Sharkya 11361, Egypt."}], "LastName": "Bishr", "ForeName": "Mokhtar", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Department, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt."}], "LastName": "Salama", "ForeName": "Osama", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt."}], "LastName": "Abulfadl", "ForeName": "Yasmin S", "Initials": "YS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Furocoumarins"}, {"RegistryNumber": "U4VJ29L7BQ", "NameOfSubstance": "Methoxsalen"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Ammi"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Furocoumarins"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Methoxsalen"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Yang J.D., Mohamed E.A., Aziz A.O.A., Shousha H.I., Hashem M.B., Nabeel M.M., Abdelmaksoud A.H., Elbaz T.M., Afihene M.Y., Duduyemi B.M., et al. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: A multicountry observational study from the Africa Liver Cancer Consortium. Lancet Gastroenterol. Hepatol. 2017;2:103\u2013111. doi: 10.1016/S2468-1253(16)30161-3.", "ArticleIdList": ["10.1016/S2468-1253(16)30161-3", "28403980"]}, {"Citation": "Wang C., Li S. Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: A single center 14 years experience from China. Medicine. 2019;98:e14070. doi: 10.1097/MD.0000000000014070.", "ArticleIdList": ["10.1097/MD.0000000000014070", "PMC6358325", "30681563"]}, {"Citation": "Ingle P.V., Samsudin S.Z., Chan P.Q., Ng M.K., Heng L.X., Yap S.C., Chai A.S.H., Wong A.S.Y. Development and novel therapeutics in hepatocellular carcinoma: A review. Ther. Clin. Risk Manag. 2016;12:445. doi: 10.2147/TCRM.S92377.", "ArticleIdList": ["10.2147/TCRM.S92377", "PMC4801152", "27042086"]}, {"Citation": "Chen S.R., Qiu H.C., Hu Y., Wang Y., Wang Y.T. Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma. Phyther. Res. 2016;30:863\u2013877. doi: 10.1002/ptr.5594.", "ArticleIdList": ["10.1002/ptr.5594", "26879574"]}, {"Citation": "Cragg G.M., Pezzuto J.M. Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents. Med. Princ. Pract. 2016;25:41\u201359. doi: 10.1159/000443404.", "ArticleIdList": ["10.1159/000443404", "PMC5588531", "26679767"]}, {"Citation": "Moreno F.S., Heidor R., Pogribny I.P. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents. Nutr. Cancer. 2016;68:719\u2013733. doi: 10.1080/01635581.2016.1180410.", "ArticleIdList": ["10.1080/01635581.2016.1180410", "27266713"]}, {"Citation": "Rawat D., Shrivastava S., Naik R.A., Chhonker S.K., Mehrotra A., Koiri R.K. An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma. Anticancer Agents Med. Chem. 2018;18:1838\u20131859. doi: 10.2174/1871520618666180604085612.", "ArticleIdList": ["10.2174/1871520618666180604085612", "29866017"]}, {"Citation": "Fathallah N., Raafat M.M., Issa M.Y., Abdel-Aziz M.M., Bishr M., Abdelkawy M.A., Salama O. Bio-guided fractionation of prenylated benzaldehyde derivatives as potent antimicrobial and antibiofilm from Ammi majus L. fruits-associated Aspergillus amstelodami. Molecules. 2019;24:4118. doi: 10.3390/molecules24224118.", "ArticleIdList": ["10.3390/molecules24224118", "PMC6891696", "31739552"]}, {"Citation": "Kausar H., Abidin L., Mujeeb M., Aqil M., Alam O. Factorial design-guided optimization of extraction of therapeutically active furanocoumarin khellin from Ammi majus L. fruits. Pharmacogn. Mag. 2020;16:835. doi: 10.4103/pm.pm_295_20.", "ArticleIdList": ["10.4103/pm.pm_295_20"]}, {"Citation": "Hossain M.A., Al Touby S. Ammi majus an Endemic Medicinal Plant: A Review of the Medicinal Uses, Pharmacological and Phytochemicals. Ann. Toxicol. 2020;2:9\u201314. doi: 10.36959/736/634.", "ArticleIdList": ["10.36959/736/634"]}, {"Citation": "Duddeck H., Kaiser M. 13C NMR spectroscopy of coumarin derivatives. Org. Magn. Reson. 1982;20:55\u201372. doi: 10.1002/mrc.1270200202.", "ArticleIdList": ["10.1002/mrc.1270200202"]}, {"Citation": "Karawya M.S., Khayyal S.E., Youssef G.F. Estimation of xanthotoxin, imperatorin and bergapten in Ammi majus fruits and formulations. Planta Med. 1970;18:195\u2013200. doi: 10.1055/s-0028-1099766.", "ArticleIdList": ["10.1055/s-0028-1099766", "5428499"]}, {"Citation": "Selim Y., Ouf N. Anti-inflammatory new coumarin from the Ammi majus L. Org. Med. Chem. Lett. 2012;2:1. doi: 10.1186/2191-2858-2-1.", "ArticleIdList": ["10.1186/2191-2858-2-1", "PMC3349536", "22373472"]}, {"Citation": "Al-Hadhrami R.M.S., Hossain M.A. Evaluation of antioxidant, antimicrobial and cytotoxic activities of seed crude extracts of Ammi majus grown in Oman. Egypt. J. Basic Appl. Sci. 2016;3:329\u2013334. doi: 10.1016/j.ejbas.2016.08.001.", "ArticleIdList": ["10.1016/j.ejbas.2016.08.001"]}, {"Citation": "Grigg R., Knight J.A., Roffey P. NMR solvent shifts and structure elucidation in coumarins. Tetrahedron. 1966;22:3301\u20133304. doi: 10.1016/S0040-4020(01)92515-3.", "ArticleIdList": ["10.1016/S0040-4020(01)92515-3"]}, {"Citation": "Razavi S.M., Zarrini G., Rad G.F. Isoarnottinin 4\u2032-glucoside, a glycosylated coumarin from Prangos uloptera, with biological activity. Russ. J. Bioorg. Chem. 2011;37:240\u2013243. doi: 10.1134/S1068162011020130.", "ArticleIdList": ["10.1134/S1068162011020130", "21717896"]}, {"Citation": "Hani M., Elgamal A., Nagwa M., Shalaby M., Duddeck H. Isolation of two Adjuncts from the Fruits of Ammi majus L. Nat. Prod. Lett. 1993;3:209\u2013212. doi: 10.1080/10575639308043865.", "ArticleIdList": ["10.1080/10575639308043865"]}, {"Citation": "Abu-Mustafa E.A., Fayez M.B.E. Natural Coumarins. I. Marmesin and Marmesinin, Further Products from the Fruits of Ammi majus L. J. Org. Chem. 1961;26:161\u2013166. doi: 10.1021/jo01060a039.", "ArticleIdList": ["10.1021/jo01060a039"]}, {"Citation": "Wang Q., Zhong S., Wu H., Wu Q. In vitro anti-cancer effect of marmesin by suppression of PI3K/Akt pathway in esophagus cancer cells. Esophagus. 2021;19:163\u2013174. doi: 10.1007/s10388-021-00872-8.", "ArticleIdList": ["10.1007/s10388-021-00872-8", "34398363"]}, {"Citation": "Luszczki J.J., Glowniak K., Czuczwar S.J. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice. Eur. J. Pharmacol. 2007;574:133\u2013139. doi: 10.1016/j.ejphar.2007.07.008.", "ArticleIdList": ["10.1016/j.ejphar.2007.07.008", "17651727"]}, {"Citation": "Abu-Mustafa E.A., El-Bay F.K.A., Fayez M.B.E. Ammirin, a new coumarin constituent from Ammi majus L. fruits-Natural coumarins, part XVI. Naturwissenschaften. 1975;62:39\u201340. doi: 10.1007/BF00594048.", "ArticleIdList": ["10.1007/BF00594048", "1134590"]}, {"Citation": "El-Fadl H.M.A., Hagag N.M., El-Shafei R.A., Khayri M.H., El-Gedawy G., El Maksoud A.I.A., Mohamed D.D., Mohamed D.D., El Halfawy I., Khoder A.I., et al. Effective Targeting of Raf-1 and Its Associated Autophagy by Novel Extracted Peptide for Treating Breast Cancer Cells. Front. Oncol. 2021;11:3317. doi: 10.3389/fonc.2021.682596.", "ArticleIdList": ["10.3389/fonc.2021.682596", "PMC8430328", "34513674"]}, {"Citation": "Sordet O., Goldman A., Pommier Y. Topoisomerase II and tubulin inhibitors both induce the formation of apoptotic topoisomerase I cleavage complexes. Mol. Cancer Ther. 2006;5:3139\u20133144. doi: 10.1158/1535-7163.MCT-06-0463.", "ArticleIdList": ["10.1158/1535-7163.MCT-06-0463", "17172417"]}, {"Citation": "Wu C.C., Li T.K., Farh L., Lin L.Y., Lin T.S., Yu Y.J., Yen T.J., Chiang C.W., Chan N.L. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science. 2011;333:459\u2013462. doi: 10.1126/science.1204117.", "ArticleIdList": ["10.1126/science.1204117", "21778401"]}, {"Citation": "Nishina S., Yamauchi A., Kawaguchi T., Kaku K., Goto M., Sasaki K., Hara Y., Tomiyama Y., Kuribayashi F., Torimura T., et al. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice. Cmgh. 2019;7:115\u2013134. doi: 10.1016/j.jcmgh.2018.08.008.", "ArticleIdList": ["10.1016/j.jcmgh.2018.08.008", "PMC6260362", "30510994"]}, {"Citation": "Arafah M.W., Almutairi B., Al-Zharani M., Alkahtane A.A., Al-Otibi F.O., Ali D., Alghamdi W.M., Alanazi I.S., Aljarba N.H., Alhoshani N.M., et al. The protective effect of Ammi visnaga extract against human hepatic cancer. J. King Saud Univ. Sci. 2021;33:101540. doi: 10.1016/j.jksus.2021.101540.", "ArticleIdList": ["10.1016/j.jksus.2021.101540"]}, {"Citation": "Voykov P., Chaushev H., Panova N. Psoralens: Pharmaceutical applications in treating proliferative skin diseases. Scr. Sci. Pharm. 2015;2:55."}, {"Citation": "Konstantinow A., Balda B.R. Treatment of cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J. Eur. Acad. Dermatol. Venereol. 1997;9:111\u2013117. doi: 10.1016/S0926-9959(97)00045-7.", "ArticleIdList": ["10.1016/S0926-9959(97)00045-7"]}, {"Citation": "Mirzaei S.A., Gholamian Dehkordi N., Ghamghami M., Amiri A.H., Dalir Abdolahinia E., Elahian F. ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells. Toxicol. Appl. Pharmacol. 2017;337:22\u201329. doi: 10.1016/j.taap.2017.10.018.", "ArticleIdList": ["10.1016/j.taap.2017.10.018", "29079042"]}, {"Citation": "Shokoohinia Y., Hosseinzadeh L., Alipour M., Mostafaie A., Mohammadi-Motlagh H.R. Comparative Evaluation of Cytotoxic and Apoptogenic Effects of Several Coumarins on Human Cancer Cell Lines: Osthole Induces Apoptosis in p53-Deficient H1299 Cells. Adv. Pharmacol. Sci. 2014;2014:1\u20138. doi: 10.1155/2014/847574.", "ArticleIdList": ["10.1155/2014/847574", "PMC4168038", "25276123"]}, {"Citation": "Li J., Yang B., Zhou Q., Wu Y., Shang D., Guo Y., Song Z., Zheng Q., Xiong J. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis. 2013;34:1343\u20131351. doi: 10.1093/carcin/bgt063.", "ArticleIdList": ["10.1093/carcin/bgt063", "23430956"]}, {"Citation": "Ouyang L., Shi Z., Zhao S., Wang F.T., Zhou T.T., Liu B., Bao J.K. Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45:487\u2013498. doi: 10.1111/j.1365-2184.2012.00845.x.", "ArticleIdList": ["10.1111/j.1365-2184.2012.00845.x", "PMC6496669", "23030059"]}, {"Citation": "Das C.K., Banerjee I., Mandal M. Seminars in Cancer Biology. Volume 66. Elsevier; Amsterdam, The Netherlands: 2020. Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer; pp. 59\u201374.", "ArticleIdList": ["31430557"]}, {"Citation": "Yu S., Wang Y., Jing L., Claret F.X., Li Q., Tian T., Liang X., Ruan Z., Jiang L., Yao Y., et al. Autophagy in the \u201cinflammation-carcinogenesis\u201d pathway of liver and HCC immunotherapy. Cancer Lett. 2017;411:82\u201389. doi: 10.1016/j.canlet.2017.09.049.", "ArticleIdList": ["10.1016/j.canlet.2017.09.049", "28987386"]}, {"Citation": "Singh S.S., Vats S., Chia A.Y.-Q.Q., Tan T.Z., Deng S., Ong M.S., Arfuso F., Yap C.T., Goh B.C., Sethi G., et al. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018;37:1142\u20131158. doi: 10.1038/s41388-017-0046-6.", "ArticleIdList": ["10.1038/s41388-017-0046-6", "29255248"]}, {"Citation": "McClendon A.K., Osheroff N. DNA topoisomerase II, genotoxicity, and cancer. Mutat. Res. Mol. Mech. Mutagen. 2007;623:83\u201397. doi: 10.1016/j.mrfmmm.2007.06.009.", "ArticleIdList": ["10.1016/j.mrfmmm.2007.06.009", "PMC2679583", "17681352"]}, {"Citation": "Ghanem A., Emara H.A., Muawia S., Abd El Maksoud A.I., Al-Karmalawy A.A., Elshal M.F. Tanshinone IIA synergistically enhances the antitumor activity of doxorubicin by interfering with the PI3K/AKT/mTOR pathway and inhibition of topoisomerase II: In vitro and molecular docking studies. New J. Chem. 2020;44:17374\u201317381. doi: 10.1039/D0NJ04088F.", "ArticleIdList": ["10.1039/D0NJ04088F"]}, {"Citation": "Das S., Tripathi N., Siddharth S., Nayak A., Nayak D., Sethy C., Bharatam P.V., Kundu C.N. Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis. Apoptosis. 2017;22:1205\u20131224. doi: 10.1007/s10495-017-1400-4.", "ArticleIdList": ["10.1007/s10495-017-1400-4", "28702823"]}, {"Citation": "Balbaa S.I., Hilal S.H., Haggag M.Y. Separation of ammajin and marmesin from the fruits of Ammi majus and their chemical estimation. Planta Med. 1973;23:191\u2013195. doi: 10.1055/s-0028-1099432.", "ArticleIdList": ["10.1055/s-0028-1099432", "4705799"]}, {"Citation": "Vichai V., Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 2006;1:1112\u20131116. doi: 10.1038/nprot.2006.179.", "ArticleIdList": ["10.1038/nprot.2006.179", "17406391"]}, {"Citation": "Mohamed S.A., Elshal M.F., Kumosani T.A., Aldahlawi A.M., Basbrain T.A., Alshehri F.A., Choudhry H. L-asparaginase isolated from Phaseolus vulgaris seeds exhibited potent anti-acute lymphoblastic leukemia effects in-vitro and low immunogenic properties in-vivo. Int. J. Environ. Res. Public Health. 2016;13:1008. doi: 10.3390/ijerph13101008.", "ArticleIdList": ["10.3390/ijerph13101008", "PMC5086747", "27754445"]}, {"Citation": "Eliaa S.G., Al-Karmalawy A.A., Saleh R.M., Elshal M.F. Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: In Vitro and Molecular Docking Studies. ACS Pharmacol. Transl. Sci. 2020;3:1330\u20131338. doi: 10.1021/acsptsci.0c00144.", "ArticleIdList": ["10.1021/acsptsci.0c00144", "PMC7737321", "33344906"]}, {"Citation": "Thom\u00e9 M.P., Filippi-Chiela E.C., Villodre E.S., Migliavaca C.B., Onzi G.R., Felipe K.B., Lenz G. Ratiometric analysis of Acridine Orange staining in the study of acidic organelles and autophagy. J. Cell Sci. 2016;129:4622\u20134632. doi: 10.1242/jcs.195057.", "ArticleIdList": ["10.1242/jcs.195057", "27875278"]}, {"Citation": "Elia S.G., Al-Karmalawy A.A., Nasr M.Y., Elshal M.F. Loperamide potentiates doxorubicin sensitivity in triple-negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl-2: In vitro and molecular docking study. J. Biochem. Mol. Toxicol. 2021;36:e22938. doi: 10.1002/jbt.22938.", "ArticleIdList": ["10.1002/jbt.22938", "34719826"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "30"}, {"Year": "2022", "Month": "1", "Day": "22"}, {"Year": "2022", "Month": "1", "Day": "25"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "1", "Minute": "20"}, {"Year": "2022", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35164207", "PMC8839012", "10.3390/molecules27030943", "molecules27030943"]}}], "PubmedBookArticle": []}